Bing Xiong

2.9k total citations
143 papers, 2.3k citations indexed

About

Bing Xiong is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Bing Xiong has authored 143 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Molecular Biology, 28 papers in Organic Chemistry and 20 papers in Oncology. Recurrent topics in Bing Xiong's work include Protein Degradation and Inhibitors (20 papers), Computational Drug Discovery Methods (16 papers) and Ubiquitin and proteasome pathways (15 papers). Bing Xiong is often cited by papers focused on Protein Degradation and Inhibitors (20 papers), Computational Drug Discovery Methods (16 papers) and Ubiquitin and proteasome pathways (15 papers). Bing Xiong collaborates with scholars based in China, Canada and United States. Bing Xiong's co-authors include Jingkang Shen, Xin Wang, Yanlian Li, Hualiang Jiang, Yue‐Lei Chen, Danqi Chen, Ao Zhang, Jing Zhang, Xuechu Zhen and Danyan Cao and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Bioinformatics.

In The Last Decade

Bing Xiong

136 papers receiving 2.2k citations

Peers

Countries citing papers authored by Bing Xiong

Since Specialization

Citations

This map shows the geographic impact of Bing Xiong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Xiong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Xiong more than expected).

Fields of papers citing papers by Bing Xiong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Xiong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Xiong. The network helps show where Bing Xiong may publish in the future.

Co-authorship network of co-authors of Bing Xiong

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Xiong. A scholar is included among the top collaborators of Bing Xiong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Xiong. Bing Xiong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	SynMSE: A multimodal similarity evaluator for complex distribution discrepancy in unsupervised deformable multimodal medical image registration 2025 ·Medical Image Analysis ·Jingke Zhu, (unknown), Bing Xiong, (unknown), (unknown), (unknown), Jing Cai, Yaoqin Xie, Wenjian Qin	0
2	Multi-Water Bridges Enable Design of BET BD1-Selective Inhibitors for Pancreatic Cancer Therapy 2025 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Tingting Wu, Danyan Cao, Yali Chen, (unknown), Yan Li, Fanying Meng, Xinyue Wang, Qidong You, Bing Xiong, Xiaoke Guo, Zhengyu Jiang	4
3	A Bibliometric Analysis of Translator’s Style in Translation Studies: A Chinese Perspective (1980–2022) 2025 ·SAGE Open ·(unknown), Bing Xiong	0
4	Design of Selective BRD4 Inhibitors for the Treatment of Autosomal Dominant Polycystic Kidney Disease 2025 ·Journal of Medicinal Chemistry ·Yueyue Yang, (unknown), (unknown), (unknown), Haiyang Zhong, Yanlian Li, Danyan Cao, Wenchao Zhao, (unknown), Bing Xiong, Danqi Chen, Dong Guo	2
5	SelfDN: Adaptive Self-Denoising for multi-view 3D object detection 2025 ·Knowledge-Based Systems ·(unknown), Menghao Yang, Yongmin Zhang, Bing Xiong, Yaping Liu, Zhaoning Zhang	1
6	Structure-Based Discovery of Potent Usp28 Inhibitors Derived from Vismodegib 2023 ·SSRN Electronic Journal ·Di Zhou, (unknown), Yaodong Huang, Hui Wang, Xiaoli Zhu, Wentao Zhang, Weiwei Song, Tong Gao, Tongchao Liu, (unknown), (unknown), Naixia Zhang, Bing Xiong	1
7	Screening and optimization of phage display cyclic peptides against the WDR5 WBM site 2023 ·RSC Medicinal Chemistry ·Lingyu Song, Jiawen Cao, (unknown), Zhiyan Du, Naixia Zhang, Danyan Cao, Bing Xiong	2
8	Constructing Chinese Cultural Identity Internationally in Translated Political Discourse: A Corpus Analysis of the English Versions of President Xi Jinping’s International Addresses 2023 ·(unknown), Bing Xiong	1
9	Advances in discourse analysis of translation and interpreting: linking linguistic approaches with socio-cultural interpretation 2023 ·Social Semiotics ·(unknown), Bing Xiong, (unknown)	0
10	The Novel RET Inhibitor SYHA1815 Inhibits RET-Driven Cancers and Overcomes Gatekeeper Mutations by Inducing G1 Cell-Cycle Arrest through c-Myc Downregulation 2021 ·Molecular Cancer Therapeutics ·(unknown), Peng Xia, Yinchun Ji, Yang Dai, Yanfen Fang, Bing Xiong, (unknown), Youhong Hu, Yi Chen, Jing Ai	9
11	Tranylcypromine and 6-trifluoroethyl thienopyrimidine hybrid as LSD1 inhibitor 2019 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Mingbo Su, You Li, Tongchao Liu, Yujie Wang, Yabing Chen, (unknown), Yu‐Peng He, (unknown), Fang Yu, Jingkang Shen, Jia Li, Yubo Zhou, Yue‐Lei Chen, Bing Xiong	11
12	Efficient syntheses of alpha- and beta-C-nucleosides and the origin of anomeric selectivity 2018 ·Organic Chemistry Frontiers ·Tongchao Liu, Zhengdan Zhu, (unknown), Yabin Chen, Guohua Chen, Maosheng Cheng, Dongmei Zhao, Jingkang Shen, Weiliang Zhu, Bing Xiong, Yue‐Lei Chen	5
13	Preclinical Evaluation of SCC244 (Glumetinib), a Novel, Potent, and Highly Selective Inhibitor of c-Met in MET-dependent Cancer Models 2017 ·Molecular Cancer Therapeutics ·Jing Ai, Yi Chen, Peng Xia, Yinchun Ji, Yong Xi, Yanyan Shen, Xinying Yang, Yi Su, Yiming Sun, Yinglei Gao, Yuchi Ma, Bing Xiong, Jingkang Shen, Jian Ding, Meiyu Geng	26
14	Discovery of a series of dihydroquinoxalin-2(1H)-ones as selective BET inhibitors from a dual PLK1-BRD4 inhibitor 2017 ·European Journal of Medicinal Chemistry ·Jianping Hu, Ying-Qing Wang, Yanlian Li, Lin Xu, Danyan Cao, Shanshan Song, (unknown), Xin Wang, Tao Meng, Yue‐Lei Chen, Jingkang Shen, Ze‐Hong Miao, Bing Xiong	30
15	FS23 binds to the N-terminal domain of human Hsp90: A novel small inhibitor for Hsp90 2015 ·《核技术》(英文版) ·(unknown), (unknown), (unknown), (unknown), Bing Xiong, (unknown), (unknown)	3
16	Discovery of pyrazole as C-terminus of selective BACE1 inhibitors 2013 ·European Journal of Medicinal Chemistry ·(unknown), Lei Xu, Wuyan Chen, Yiping Zhu, Tiantian Chen, Yan Fu, Li Li, Lanping Ma, Bing Xiong, Xin Wang, Jian Li, Jianhua He, Haiyan Zhang, Yechun Xu, Jia Li, Jingkang Shen	21
17	Hemodynamics assessment by perfusion computed tomography in a canine model of portal hypertension 2011 ·Zhonghua putong waike zazhi ·(unknown), Weijian Chen, Yunjun Yang, Liang Pan, (unknown), (unknown), Bing Xiong	1
18	Crystal Structures of Two Aminoglycoside Kinases Bound with a Eukaryotic Protein Kinase Inhibitor 2011 ·PLoS ONE ·(unknown), Bing Xiong, Ji‐Young Hwang, Albert M. Berghuis	26
19	DrugViz: a Cytoscape plugin for visualizing and analyzing small molecule drugs in biological networks 2008 ·Bioinformatics ·Bing Xiong, (unknown), Jie Wu, David L. Burk, Hualiang Jiang, Jingkang Shen	14
20	The potential receptor for high mobility group box-1 protein （HMGB1） on immune function of peritoneal macrophages in mnice 2007 ·Zhonghua shiyan waike zazhi ·(unknown), (unknown), (unknown), (unknown), (unknown), Bing Xiong	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact